Trial Profile
Effects of coadministering maraviroc with darunavir + ritonavir on the pharmacokinetics of maraviroc in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Mar 2011
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary) ; Darunavir; Ritonavir
- Indications HIV infections; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Pfizer Global Research and Development; Tibotec Inc
- 11 Mar 2011 New trial record